Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK
Lynn T. Singer, Derek G. Moore, Meeyoung O. Min, Julia Goodwin, J. Turner, Sarah Fulton, Andrew C. Parrott
Human Psychopharmacology July 1, 2015 DOI: 10.1002/hup.2459 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Longitudinal study Peer reviewed |
|---|---|
| Population | Infants with prenatal MDMA exposure |
| Topics | MDMA |
| Citations | 16 |
| Key findings | Prenatal MDMA exposure may be associated with motor development delays in infancy, with effects appearing dose-dependent. |
Abstract
This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, “ecstasy”) on infant development.